Canavanine



Compound IDCDAMM00773
Common nameCanavanine
IUPAC name2-amino-4-(diaminomethylideneamino)oxybutanoic acid
Molecular formulaC5H12N4O3

Experimental data

Retention time0.44
Adduct[M+K]+
Actual mz215.057
Theoretical mz215.054
Error12.75
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.0162

Identifiers and class information

Inchi keyFSBIGDSBMBYOPN-VKHMYHEASA-N
SmilesO=C(O)C(N)CCONC(=N)N
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)176.175
Computed dipole moment(dipole)10.718
Total solvent accessible surface area (SASA)386.297
Hydrophobic component of SASA (FOSA)88.515
Hydrophilic component of SASA (FISA)297.782
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)603.122
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)6.7
Free energy of solvation of dipole (dip^2/V)0.190482
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0458884
Globularity descriptor (glob)0.893678
Predicted polarizability in cubic angstroms (QPpolrz)13.488
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.43
Predicted octanol/gas partition coefficient (QPlogPoct)20.744
Predicted water/gas partition coefficient (QPlogPw)17.982
Predicted octanol/water partition coefficient (QPlogPo/w)-4.043
Predicted aqueous solubility (QPlogS)-0.111
Conformation-independent predicted aqueous solubility (CIQPlogS)0.315
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.171
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.939
Predicted brain/blood partition coefficient (QPlogBB)-1.946
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.372
Predicted skin permeability, log Kp (QPlogKp)-8.398
PM3 calculated ionization potential (IP(ev))8.459
PM3 calculated electron affinity (EA(eV))-1.092
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.185
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)154.618
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29475NOS1Nitric-oxide synthase, brainT16117SEA
P35228NOS2Nitric oxide synthase, inducibleT02703SwissTargetPrediction and SEA
P29474NOS3Nitric-oxide synthase, endothelialT06046SEA
P09960LTA4HLeukotriene A4 hydrolaseT03691SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P28335HTR2CSerotonin 2c (5-HT2c) receptorT83813SwissTargetPrediction
P41595HTR2BSerotonin 2b (5-HT2b) receptorT31204SwissTargetPrediction
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
Q9H4A4RNPEPAminopeptidase BT57818SEA
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
Q9ULA0DNPEPAspartyl aminopeptidaseT45287SEA
P05089ARG1Arginase-1 (by homology)T63224SwissTargetPrediction and SEA
P00480OTCOrnithine transcarbamylaseT52098SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16117DI0173Headache[ICD-11: 8A80-8A84]P29475NOS1
T16117DI0264Migraine[ICD-11: 8A80]P29475NOS1
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T06046DI0287Myocardial infarction[ICD-11: BA41-BA43]P29474NOS3
T03691DI0012Acute myeloid leukaemia[ICD-11: 2A60]P09960LTA4H
T83813DI0117Depression[ICD-11: 6A70-6A7Z]P28335HTR2C
T83813DI0264Migraine[ICD-11: 8A80]P28335HTR2C
T83813DI0308Obesity[ICD-11: 5B80-5B81]P28335HTR2C
T83813DI0324Pain[ICD-11: MG30-MG3Z]P28335HTR2C
T83813DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P28335HTR2C
T31204DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]P41595HTR2B
T31204DI0117Depression[ICD-11: 6A70-6A7Z]P41595HTR2B
T31204DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P41595HTR2B
T31204DI0354Psychotic disorder[ICD-11: 6A20-6A25]P41595HTR2B
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T45287DI0190Hypertension[ICD-11: BA00-BA04]Q9ULA0DNPEP
T63224DI0258Metabolism inborn error[ICD-11: 5C50]P05089ARG1
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC

Copyright © 2025